Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

51.06 

0.41 0.8%

as of Feb 15 '19

52 Week Range:

42.14 67.50


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. Integra LifeSciences Holdings Corporation offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 5.02
6.33
7.78
8.76
9.35
9.26
7.77
10.48
9.88
11.02
11.65
growth rate 26.1% 22.9% 12.6% 6.7% -1.0% -16.1% 34.9% -5.7% 11.5% 5.7%
Earnings BIT 60.06
31.01
73.15
82.11
28.49
52.03
-24.79
125.81
136.73
159.27
176.89
growth rate -48.4% 135.9% 12.3% -65.3% 82.6% -100.0% 100.0% 8.7% 16.5% 11.1%
Avg.PE 37.04
29.24
21.19
21.74
32.47
26.95
-130.21
57.43
49.07
55.12
86.25
growth rate -21.1% -27.5% 2.6% 49.4% -17.0% -100.0% 100.0% -14.6% 12.3% 56.5%
ROA 4.68
3.77
5.16
6.71
2.59
3.57
-1.44
2.45
-0.21
4.16
2.58
growth rate -19.4% 36.9% 30.0% -61.4% 37.8% -100.0% 100.0% -100.0% 100.0% -38.0%
ROE 12.03
11.44
12.82
13.90
5.64
8.16
-2.86
4.95
-0.48
9.37
7.19
growth rate -4.9% 12.1% 8.4% -59.4% 44.7% -100.0% 100.0% -100.0% 100.0% -23.3%
ROIC 6.54
4.23
7.53
9.25
6.01
5.61
-0.35
4.27
-0.06
6.48
12.02
growth rate -35.3% 78.0% 22.8% -35.0% -6.7% -100.0% 100.0% -100.0% 100.0% 85.5%
Cur. Ratio 1.77
2.85
2.33
2.22
4.44
4.24
4.40
4.20
3.15
4.01
2.36
growth rate 61.0% -18.3% -4.7% 100.0% -4.5% 3.8% -4.6% -25.0% 27.3% -41.2%
Quick Ratio 0.84
1.69
1.12
1.17
2.15
1.98
2.00
1.62
1.30
2.02
1.22
growth rate 101.2% -33.7% 4.5% 83.8% -7.9% 1.0% -19.0% -19.8% 55.4% -39.6%
Leverage 3.14
2.95
2.11
2.03
2.32
2.25
1.78
2.24
2.36
2.15
3.34
growth rate -6.1% -28.5% -3.8% 14.3% -3.0% -20.9% 25.8% 5.4% -8.9% 55.4%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 112.40
103.20
106.00
154.28
154.02
166.76
110.41
132.24
148.19
251.80
growth rate -8.2% 2.7% 45.6% -0.2% 8.3% -33.8% 19.8% 12.1% 69.9%
Acct.Payable 97.33
103.42
115.19
28.87
34.77
29.06
93.97
growth rate 6.3% 11.4% -74.9% 20.5% -16.4% 223.4%
Cur.Assets 497.40
365.40
444.80
452.26
453.05
521.15
529.32
438.50
495.17
822.15
growth rate -26.5% 21.7% 1.7% 0.2% 15.0% 1.6% -17.2% 12.9% 66.0%
Total Assets 1,026.00
940.10
1,017.30
1,144.11
1,163.60
1,192.14
1,587.42
1,774.22
1,807.95
3,211.26
growth rate -8.4% 8.2% 12.5% 1.7% 2.5% 33.2% 11.8% 1.9% 77.6%
Cash 183.50
71.90
128.80
100.81
96.94
120.61
71.73
48.13
102.06
174.94
growth rate -60.8% 79.1% -21.7% -3.8% 24.4% -40.5% -32.9% 112.0% 71.4%
Inventory 146.10
140.20
146.90
171.26
171.81
206.92
189.13
211.43
217.26
296.33
growth rate -4.0% 4.8% 16.6% 0.3% 20.4% -8.6% 11.8% 2.8% 36.4%
Cur.Liabilities 174.80
156.70
200.00
101.87
106.93
119.38
126.03
139.13
123.60
348.91
growth rate -10.4% 27.6% -49.1% 5.0% 11.7% 5.6% 10.4% -11.2% 182.3%
Liabilities 653.70
495.20
517.30
651.47
645.82
526.05
883.10
1,022.78
968.29
2,248.95
growth rate -24.3% 4.5% 25.9% -0.9% -18.6% 67.9% 15.8% -5.3% 132.3%
LT Debt 330.00
459.50
308.80
294.80
532.26
519.55
392.06
626.25
700.12
665.00
1,782.72
growth rate 39.2% -32.8% -4.5% 80.6% -2.4% -24.5% 59.7% 11.8% -5.0% 168.1%
Equity 260.43
372.30
444.90
500.00
492.64
517.78
666.09
704.32
751.44
839.67
962.31
growth rate 43.0% 19.5% 12.4% -1.5% 5.1% 28.6% 5.7% 6.7% 11.7% 14.6%
Common Shares 59.00
57.00
59.00
60.00
59.00
57.00
58.00
66.00
71.00
79.00
79.00
growth rate -3.4% 3.5% 1.7% -1.7% -3.4% 1.8% 13.8% 7.6% 11.3% 0.0%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 22.57
13.40
25.20
37.10
38.43
69.03
42.30
38.34
33.41
47.33
43.50
growth rate -40.6% 88.1% 47.2% 3.6% 79.7% -38.7% -9.4% -12.9% 41.7% -8.1%
Cash Dividends 0.00
0.00
0.00
0.00
0.00
0.00
47.01
47.01
growth rate 0.0%
Cash From OA 47.03
72.60
143.20
105.60
104.33
59.10
53.27
83.57
104.85
116.41
114.54
growth rate 54.4% 97.3% -26.3% -1.2% -43.4% -9.9% 56.9% 25.5% 11.0% -1.6%
FCF per Share 0.41
1.03
1.97
1.13
0.91
-0.18
-0.44
0.47
0.81
1.07
0.74
growth rate 151.2% 91.3% -42.6% -19.5% -100.0% 0.0% 100.0% 72.3% 32.1% -30.8%
Sale Purchase of Stock -51.32
0.70
154.80
15.22
227.01
10.48
9.77
growth rate 100.0% 22,141.7% -90.2% 1,392.0% -95.4% -6.8%
FCF 24.00
59.00
116.00
68.00
66.00
-10.00
5.00
37.00
61.00
69.00
71.00
growth rate 145.8% 96.6% -41.4% -2.9% -100.0% 100.0% 640.0% 64.9% 13.1% 2.9%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 550.46
654.60
682.50
732.10
780.08
830.87
696.83
796.72
882.73
992.08
1,188.24
growth rate 18.9% 4.3% 7.3% 6.6% 6.5% -16.1% 14.3% 10.8% 12.4% 19.8%
Op.Income 47.40
97.80
98.70
27.99
41.20
22.03
125.81
136.73
159.27
176.89
growth rate 106.3% 0.9% -71.6% 47.2% -46.5% 471.2% 8.7% 16.5% 11.1%
IBT 18.50
73.20
82.10
28.49
52.03
18.79
45.57
60.67
90.41
11.39
growth rate 295.7% 12.2% -65.3% 82.6% -63.9% 142.6% 33.2% 49.0% -87.4%
Net Income 27.70
51.00
65.70
27.99
41.20
22.03
34.00
-3.52
74.56
64.74
growth rate 84.1% 28.8% -57.4% 47.2% -46.5% 54.4% -100.0% 100.0% -13.2%
EPS 0.56
0.48
0.87
1.08
0.47
0.72
-0.37
0.52
-0.05
0.94
0.82
growth rate -14.3% 81.3% 24.1% -56.5% 53.2% -100.0% 100.0% -100.0% 100.0% -12.8%
Gross Profit 335.79
401.80
437.60
463.90
480.93
516.44
417.28
510.87
573.61
661.86
781.14
growth rate 19.7% 8.9% 6.0% 3.7% 7.4% -19.2% 22.4% 12.3% 15.4% 18.0%
R&D 60.50
44.30
48.10
51.45
51.01
42.62
43.06
49.94
57.96
63.46
growth rate -26.8% 8.6% 7.0% -0.9% -16.5% 1.0% 16.0% 16.1% 9.5%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 42.04
60.55
57.52
61.29
59.22
growth rate 44.0% -5.0% 6.6% -3.4%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 171.13
251.80
277.12
263.24
251.81
growth rate 47.1% 10.1% -5.0% -4.3%
Acct.Payable 40.74
93.97
87.00
84.04
86.38
growth rate 130.7% -7.4% -3.4% 2.8%
Cur.Assets 944.94
822.15
848.65
821.32
827.98
growth rate -13.0% 3.2% -3.2% 0.8%
Total Assets 2,418.19
3,211.26
3,247.69
3,185.77
3,178.64
growth rate 32.8% 1.1% -1.9% -0.2%
Cash 481.94
174.94
189.40
183.77
205.99
growth rate -63.7% 8.3% -3.0% 12.1%
Inventory 232.34
296.33
290.47
290.52
290.85
growth rate 27.5% -2.0% 0.0% 0.1%
Cur.Liabilities 210.23
348.91
336.02
233.34
258.34
growth rate 66.0% -3.7% -30.6% 10.7%
Liabilities 1,505.07
2,248.95
2,249.25
1,843.87
1,813.56
growth rate 49.4% 0.0% -18.0% -1.6%
LT Debt 1,152.63
1,782.72
1,772.03
1,476.49
1,421.00
growth rate 54.7% -0.6% -16.7% -3.8%
Equity 913.12
962.31
998.44
1,341.91
1,365.08
growth rate 5.4% 3.8% 34.4% 1.7%
Common Shares 0.81
0.81
0.82
0.88
0.88
growth rate 0.0% 0.5% 7.3% 0.3%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 7.80
13.70
15.39
20.00
16.67
growth rate 75.7% 12.3% 30.0% -16.7%
Cash Dividends
growth rate
Cash From OA 45.24
11.55
41.53
36.21
79.25
growth rate -74.5% 259.6% -12.8% 118.9%
Sale Purchase of Stock 3.66
3.66
3.66
349.66
growth rate 0.0% 0.0% 9,448.4%
FCF 37.45
-2.15
26.14
16.21
62.58
growth rate -100.0% 100.0% -38.0% 286.0%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 278.83
368.60
357.08
366.19
365.85
growth rate 32.2% -3.1% 2.6% -0.1%
Op.Income 42.04
60.55
57.52
61.29
59.22
growth rate 44.0% -5.0% 6.6% -3.4%
IBT 3.24
-4.60
9.13
12.73
11.02
growth rate -100.0% 100.0% 39.4% -13.4%
Net Income 3.16
44.36
10.99
11.38
13.30
growth rate 1,304.1% -75.2% 3.5% 16.9%
EPS
growth rate
Gross Profit 184.51
235.99
226.15
238.26
236.78
growth rate 27.9% -4.2% 5.4% -0.6%
R&D 15.03
17.18
18.33
19.11
20.31
growth rate 14.3% 6.7% 4.3% 6.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (59.14)

YOY Growth Grade:

D (44.18)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 52.42 52.42 19.27
EPS / Growth 11.4% 0.97 14.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.4% 12.6% 12.6%
Future PE 19.27 32.30 32.30
Future EPS 2.87 3.19 3.19
Value Price
MOS %
13.68
-73.2%
25.47
-50.1%
25.47
-50.1%
MOS Price 6.84 12.74 12.74
IRT 17.12 16.22 16.22

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.